Key result
High-dose influenza vaccination lacks reported quantitative outcome data in patients with ASCVD.
Why the study?
Preexisting atherosclerotic cardiovascular disease appears to increase severe clinical outcomes in hospitalized influenza patients, and while standard-dose inactivated influenza vaccines may decrease cardiovascular events, the evidence base remains limited.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pareek et al. (2026) studied Atherosclerotic cardiovascular disease (ASCVD). High-dose influenza vaccination vs. Standard-dose inactivated influenza vaccines (SD-IIVs) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: